prednisone alone
Showing 1 - 25 of >10,000
Idiopathic Membranous Nephropathy Trial in Beijing (Prednisone, MP and CTX)
Terminated
- Idiopathic Membranous Nephropathy
- Prednisone
- MP and CTX
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Feb 2, 2022
Peripheral T Cell Lymphoma Trial in Harlingen (Belinostat Injection, Pralatrexate Injection, CHOP)
Not yet recruiting
- Peripheral T Cell Lymphoma
- Belinostat Injection
- +3 more
-
Harlingen, TexasValley Cancer Associates
Oct 16, 2023
Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,
Not yet recruiting
- Androgen-Independent Prostatic Cancer
- +8 more
- lorigerlimab
- +2 more
- (no location specified)
May 4, 2023
DLBCL Trial in Houston (Acalabrutinib, Cyclophosphamide, Doxorubicin Hydrochloride)
Recruiting
- Diffuse Large B-Cell Lymphoma
- Acalabrutinib
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 10, 2022
Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Ann Arbor Stage II Primary Mediastinal (Thymic) Large
Recruiting
- Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- +3 more
- Brentuximab Vedotin
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Feb 10, 2022
Treatment-na?ve Mantle Cell Lymphoma Trial in China (Orelabrutinib and R-CHOP, R-CHOP)
Not yet recruiting
- Treatment-naїve Mantle Cell Lymphoma
- Orelabrutinib and R-CHOP
- R-CHOP
-
Hefei, Anhui, China
- +21 more
Dec 8, 2021
Prostate Cancer Trial in Canada (Docetaxel, Reolysin and Prednisone, Docetaxel and Prednisone)
Completed
- Prostate Cancer
- Docetaxel, Reolysin and Prednisone
- Docetaxel and Prednisone
-
Calgary, Alberta, Canada
- +10 more
Apr 6, 2020
Follicular Lymphoma, Lymphoma, Follicular Trial in United States (Zevalin Therapeutic Regimen, R-CVP)
Terminated
- Follicular Lymphoma
- Lymphoma, Follicular
- Zevalin Therapeutic Regimen
- R-CVP
-
Jacksonville, Florida
- +5 more
Dec 16, 2021
Prostate Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Cabazitaxel)
Active, not recruiting
- Prostate Cancer
- Nivolumab
- +3 more
-
Tucson, Arizona
- +59 more
Dec 22, 2022
Prostate Cancer Trial in Canada, United States (custirsen sodium, docetaxel, prednisone)
Completed
- Prostate Cancer
- custirsen sodium
- +2 more
-
Seattle, Washington
- +12 more
Apr 6, 2020
Ann Arbor Stage III DLBCL, Ann Arbor Stage IIX (Bulky) DLBCL, Ann Arbor Stage IV DLBCL Trial in United States (drug, other,
Suspended
- Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
- +20 more
- Cyclophosphamide
- +6 more
-
Tucson, Arizona
- +110 more
Jan 31, 2023
Langerhans Cell Histiocytosis of Bone Trial in Shanghai (Prednisone)
Recruiting
- Langerhans Cell Histiocytosis of Bone
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Oct 15, 2023
Duchenne Muscular Dystrophy (DMD) Trial in Gainesville (Prednisone, In-home Exercise Training, Prednisone plus exercise)
Recruiting
- Duchenne Muscular Dystrophy (DMD)
- Prednisone
- +2 more
-
Gainesville, FloridaUniversity of Florida
Feb 28, 2022
Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy Trial in France (Abiraterone)
Completed
- Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
-
Bordeaux, France
- +4 more
May 18, 2022
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Prostate Cancer Trial in Honolulu (Denosumab, Enzalutamide, Abiraterone)
Terminated
- Prostate Cancer
- Denosumab
- +3 more
-
Honolulu, HawaiiUniversity of Hawaii Cancer Center
Nov 6, 2019
Multiple Myeloma Trial in Torino (velcade subcutaneous melphalan prednisone, velcade cyclophosphamide prednisone, velcade
Active, not recruiting
- Multiple Myeloma
- velcade subcutaneous melphalan prednisone
- +2 more
-
Torino, ItalyA.O.U. Città della Salute e della Scienza di Torino - SC Ematolo
Mar 24, 2022
Lymphoma, Adult T-Cell Leukemia/Lymphoma, Lymphatic Diseases Trial in Hollywood, Boston, Chapel Hill (Brentuximab Vedotin, CHEP)
Active, not recruiting
- Lymphoma
- +2 more
- Brentuximab Vedotin
- CHEP
-
Hollywood, Florida
- +3 more
Nov 30, 2022
Inflammatory Arthritis, Immune-related Adverse Event Trial (Adalimumab, Prednisone)
Not yet recruiting
- Inflammatory Arthritis
- Immune-related Adverse Event
- (no location specified)
Sep 13, 2023
Metastatic Castrate Sensitive Prostate Cancer Trial in Worldwide (Niraparib, Abiraterone acetate (AA), Prednisone)
Recruiting
- Metastatic Castrate Sensitive Prostate Cancer
- Niraparib
- +3 more
-
Homewood, Alabama
- +439 more
Jan 17, 2023
Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Abiraterone Acetate,
Active, not recruiting
- Metastatic Prostate Carcinoma
- +2 more
- Abiraterone Acetate
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Feb 23, 2022
ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)
Recruiting
- ANCA-associated Vasculitis
- Maintenance Therapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2023
Prostate Cancer Trial in United States (Abiraterone acetate, Abiraterone acetate plus degarelix, Degarelix)
Completed
- Prostate Cancer
- Abiraterone acetate
- +2 more
-
Chicago, Illinois
- +15 more
Oct 25, 2021